| 9.1 |
27.4 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 3.3 |
10.0 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 3.2 |
9.6 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 3.0 |
9.1 |
GO:0030421 |
defecation(GO:0030421) |
| 3.0 |
9.1 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 2.8 |
8.3 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 2.6 |
7.8 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 2.4 |
7.1 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 2.3 |
11.7 |
GO:0030091 |
protein repair(GO:0030091) |
| 2.0 |
8.2 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.9 |
7.8 |
GO:0002339 |
B cell selection(GO:0002339) |
| 1.7 |
7.0 |
GO:0032610 |
interleukin-1 alpha production(GO:0032610) |
| 1.6 |
9.9 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 1.6 |
4.7 |
GO:2001139 |
negative regulation of postsynaptic membrane organization(GO:1901627) negative regulation of dendritic spine maintenance(GO:1902951) negative regulation of phospholipid efflux(GO:1902999) regulation of lipid transport across blood brain barrier(GO:1903000) negative regulation of lipid transport across blood brain barrier(GO:1903001) positive regulation of lipid transport across blood brain barrier(GO:1903002) negative regulation of phospholipid transport(GO:2001139) |
| 1.6 |
4.7 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) terminal web assembly(GO:1902896) |
| 1.4 |
8.6 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 1.4 |
4.1 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 1.3 |
5.4 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 1.3 |
4.0 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 1.2 |
2.4 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 1.2 |
4.8 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 1.1 |
17.3 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 1.0 |
5.2 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 1.0 |
3.0 |
GO:1900673 |
olefin metabolic process(GO:1900673) |
| 1.0 |
7.1 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 1.0 |
4.0 |
GO:0035934 |
corticosterone secretion(GO:0035934) |
| 1.0 |
6.0 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 1.0 |
3.0 |
GO:0090526 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 1.0 |
3.9 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.9 |
7.5 |
GO:0051255 |
spindle midzone assembly(GO:0051255) |
| 0.9 |
2.6 |
GO:0002586 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.9 |
3.5 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.9 |
3.5 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.8 |
2.5 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.8 |
3.4 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.8 |
2.5 |
GO:0030862 |
neuroblast division in subventricular zone(GO:0021849) regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.8 |
2.5 |
GO:0014028 |
notochord formation(GO:0014028) negative regulation of lymphangiogenesis(GO:1901491) |
| 0.8 |
2.5 |
GO:0048818 |
positive regulation of hair follicle maturation(GO:0048818) positive regulation of catagen(GO:0051795) regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 0.8 |
2.5 |
GO:2000569 |
T-helper 2 cell activation(GO:0035712) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.8 |
3.3 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.8 |
2.4 |
GO:0045014 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) detection of glucose(GO:0051594) |
| 0.8 |
4.0 |
GO:0071038 |
nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
| 0.8 |
3.2 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.8 |
3.1 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.8 |
3.8 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.8 |
3.0 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.7 |
2.9 |
GO:0060161 |
positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.7 |
3.6 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.7 |
3.6 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.7 |
2.9 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.7 |
2.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.7 |
2.9 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.7 |
3.5 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.7 |
2.1 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.7 |
3.4 |
GO:0019659 |
lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.7 |
3.4 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.7 |
5.4 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.7 |
2.7 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.7 |
3.3 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.7 |
2.6 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.7 |
3.3 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.6 |
4.0 |
GO:2000781 |
DNA dealkylation involved in DNA repair(GO:0006307) positive regulation of double-strand break repair(GO:2000781) |
| 0.6 |
1.7 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) regulation of interleukin-6-mediated signaling pathway(GO:0070103) negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
| 0.6 |
3.9 |
GO:0051461 |
positive regulation of heat generation(GO:0031652) corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.6 |
2.8 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.6 |
1.1 |
GO:0010579 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 0.5 |
3.7 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.5 |
3.7 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.5 |
4.3 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.5 |
2.1 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) resolution of recombination intermediates(GO:0071139) |
| 0.5 |
1.5 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.5 |
2.5 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.5 |
5.0 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.5 |
3.5 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.5 |
3.4 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.5 |
1.9 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.5 |
2.4 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.5 |
0.5 |
GO:0006551 |
leucine metabolic process(GO:0006551) |
| 0.5 |
3.8 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.5 |
1.4 |
GO:2000256 |
thrombopoietin-mediated signaling pathway(GO:0038163) positive regulation of male germ cell proliferation(GO:2000256) |
| 0.5 |
2.3 |
GO:0009125 |
nucleoside monophosphate catabolic process(GO:0009125) |
| 0.4 |
1.3 |
GO:0007521 |
muscle cell fate determination(GO:0007521) mammary placode formation(GO:0060596) |
| 0.4 |
1.7 |
GO:0070814 |
hydrogen sulfide biosynthetic process(GO:0070814) |
| 0.4 |
1.7 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.4 |
1.7 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.4 |
6.9 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.4 |
4.7 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.4 |
2.9 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.4 |
1.3 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.4 |
3.7 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.4 |
1.2 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
| 0.4 |
3.6 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.4 |
1.2 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.4 |
2.4 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.4 |
1.6 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.4 |
1.2 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.4 |
2.7 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.4 |
8.8 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.4 |
1.1 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.4 |
1.1 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.4 |
0.7 |
GO:1904395 |
positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.4 |
8.3 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.4 |
1.4 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) |
| 0.3 |
4.2 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.3 |
0.7 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 0.3 |
2.1 |
GO:0050855 |
regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.3 |
0.7 |
GO:0000050 |
urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.3 |
1.3 |
GO:0032788 |
saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
| 0.3 |
1.6 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.3 |
1.9 |
GO:0006172 |
ADP biosynthetic process(GO:0006172) |
| 0.3 |
1.3 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.3 |
0.9 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.3 |
1.2 |
GO:0071726 |
response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.3 |
2.1 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.3 |
2.1 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.3 |
1.8 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.3 |
4.1 |
GO:0060055 |
angiogenesis involved in wound healing(GO:0060055) |
| 0.3 |
2.7 |
GO:0033630 |
positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 0.3 |
0.8 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.3 |
1.6 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.3 |
1.3 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.3 |
3.5 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.3 |
1.8 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.3 |
2.0 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.3 |
2.0 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.3 |
1.3 |
GO:0032261 |
purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
| 0.2 |
0.5 |
GO:0014834 |
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 0.2 |
0.7 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.2 |
1.7 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.2 |
1.5 |
GO:0098734 |
protein depalmitoylation(GO:0002084) positive regulation of pinocytosis(GO:0048549) macromolecule depalmitoylation(GO:0098734) |
| 0.2 |
6.4 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.2 |
1.0 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.2 |
1.2 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.2 |
3.0 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.2 |
4.0 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.2 |
1.8 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 0.2 |
0.7 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 |
3.0 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.2 |
0.9 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.2 |
1.1 |
GO:0046645 |
positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 0.2 |
2.5 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 |
1.3 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.2 |
3.3 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.2 |
1.3 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.2 |
1.9 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.2 |
1.9 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.2 |
3.6 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.2 |
0.6 |
GO:0061588 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.2 |
1.1 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.2 |
1.3 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.2 |
0.4 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
| 0.2 |
2.3 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) |
| 0.2 |
0.4 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.2 |
0.6 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.2 |
3.6 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.2 |
1.2 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.2 |
1.2 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.2 |
0.6 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.2 |
0.6 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 |
0.4 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.2 |
1.3 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.2 |
0.7 |
GO:0018343 |
protein farnesylation(GO:0018343) negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.2 |
0.6 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.2 |
5.3 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.2 |
2.9 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.2 |
5.7 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.2 |
2.3 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.2 |
2.9 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.2 |
8.7 |
GO:0035690 |
cellular response to drug(GO:0035690) |
| 0.2 |
0.9 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.2 |
1.9 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.2 |
0.7 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.2 |
1.7 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.2 |
1.0 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.2 |
4.4 |
GO:0040036 |
regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
| 0.2 |
6.7 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.2 |
0.6 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.2 |
2.2 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.2 |
8.3 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.2 |
0.5 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 |
1.2 |
GO:0070633 |
transepithelial transport(GO:0070633) |
| 0.2 |
0.6 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.2 |
0.5 |
GO:0032497 |
detection of molecule of bacterial origin(GO:0032490) detection of lipopolysaccharide(GO:0032497) |
| 0.1 |
4.3 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.1 |
0.9 |
GO:0045835 |
meiotic cell cycle checkpoint(GO:0033313) negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 |
0.9 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 |
0.6 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.1 |
0.6 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.1 |
1.6 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 |
1.7 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.1 |
1.0 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.1 |
0.7 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.1 |
0.8 |
GO:1903887 |
motile primary cilium assembly(GO:1903887) |
| 0.1 |
0.9 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.1 |
2.1 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.1 |
1.2 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) |
| 0.1 |
6.1 |
GO:0071774 |
response to fibroblast growth factor(GO:0071774) |
| 0.1 |
0.8 |
GO:0097369 |
sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
2.0 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.1 |
2.4 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.1 |
0.6 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.1 |
0.4 |
GO:0072683 |
T cell extravasation(GO:0072683) |
| 0.1 |
2.2 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.1 |
0.4 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.1 |
1.2 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 |
0.8 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.1 |
2.5 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.1 |
3.2 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.1 |
1.0 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.1 |
2.1 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.1 |
1.3 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.1 |
0.9 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.1 |
0.7 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.1 |
0.9 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.1 |
0.2 |
GO:0001788 |
antibody-dependent cellular cytotoxicity(GO:0001788) |
| 0.1 |
1.3 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
0.7 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
3.2 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.1 |
4.8 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.1 |
0.3 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) |
| 0.1 |
1.3 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.1 |
0.5 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.1 |
1.3 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
3.6 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.1 |
1.5 |
GO:0052646 |
alditol phosphate metabolic process(GO:0052646) |
| 0.1 |
1.8 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.1 |
2.4 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
| 0.1 |
0.6 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.1 |
0.6 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.1 |
1.5 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.1 |
2.3 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.1 |
0.2 |
GO:0060431 |
primary lung bud formation(GO:0060431) |
| 0.1 |
0.7 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.1 |
0.3 |
GO:0032382 |
positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) positive regulation of cholesterol import(GO:1904109) positive regulation of sterol import(GO:2000911) |
| 0.1 |
0.7 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.1 |
1.6 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.1 |
0.9 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.1 |
0.2 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.1 |
0.7 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.1 |
0.5 |
GO:1903352 |
ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.1 |
0.8 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 |
4.3 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.1 |
1.3 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.4 |
GO:0032463 |
regulation of protein homooligomerization(GO:0032462) negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 |
0.1 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 |
0.2 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.1 |
2.3 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.1 |
0.3 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
0.4 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.1 |
0.6 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.1 |
1.3 |
GO:0002183 |
cytoplasmic translational initiation(GO:0002183) |
| 0.1 |
1.7 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.1 |
2.4 |
GO:0031050 |
dsRNA fragmentation(GO:0031050) production of miRNAs involved in gene silencing by miRNA(GO:0035196) production of small RNA involved in gene silencing by RNA(GO:0070918) |
| 0.1 |
4.1 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.1 |
0.5 |
GO:1903894 |
regulation of IRE1-mediated unfolded protein response(GO:1903894) |
| 0.1 |
0.3 |
GO:0060903 |
regulation of meiosis I(GO:0060631) positive regulation of meiosis I(GO:0060903) |
| 0.1 |
1.8 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 |
0.2 |
GO:0071638 |
negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.1 |
0.3 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.1 |
0.2 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.1 |
1.5 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.1 |
0.7 |
GO:0021670 |
lateral ventricle development(GO:0021670) |
| 0.1 |
0.5 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.1 |
2.4 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.1 |
0.9 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.1 |
0.8 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.1 |
0.7 |
GO:0010829 |
negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
| 0.1 |
0.6 |
GO:0000731 |
DNA synthesis involved in DNA repair(GO:0000731) |
| 0.1 |
2.9 |
GO:0046847 |
filopodium assembly(GO:0046847) |
| 0.0 |
4.7 |
GO:0007050 |
cell cycle arrest(GO:0007050) |
| 0.0 |
0.1 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.0 |
1.1 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 |
3.3 |
GO:0008584 |
male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.0 |
0.0 |
GO:2000209 |
regulation of anoikis(GO:2000209) |
| 0.0 |
0.3 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.0 |
1.5 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.2 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.0 |
0.3 |
GO:0010748 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.0 |
0.1 |
GO:0061724 |
lipophagy(GO:0061724) |
| 0.0 |
1.0 |
GO:0045580 |
regulation of T cell differentiation(GO:0045580) |
| 0.0 |
0.5 |
GO:1990090 |
response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.0 |
0.4 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 |
2.9 |
GO:0090305 |
nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
| 0.0 |
3.0 |
GO:1903749 |
positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 |
3.0 |
GO:0007368 |
determination of left/right symmetry(GO:0007368) |
| 0.0 |
0.7 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.0 |
0.7 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.0 |
4.8 |
GO:0050658 |
nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
| 0.0 |
0.1 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.0 |
1.2 |
GO:0033014 |
porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.0 |
0.2 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.0 |
0.3 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.0 |
0.1 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
1.5 |
GO:0042475 |
odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.0 |
0.4 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 |
0.4 |
GO:0050829 |
defense response to Gram-negative bacterium(GO:0050829) |
| 0.0 |
0.2 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.0 |
0.1 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.0 |
0.2 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
1.1 |
GO:0030500 |
regulation of bone mineralization(GO:0030500) |
| 0.0 |
0.2 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.0 |
0.3 |
GO:0046185 |
aldehyde catabolic process(GO:0046185) |
| 0.0 |
0.3 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 |
1.0 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.0 |
0.0 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.0 |
1.3 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.0 |
0.6 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.0 |
0.2 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.3 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.1 |
GO:0048821 |
erythrocyte development(GO:0048821) |
| 0.0 |
0.1 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.0 |
2.1 |
GO:0043062 |
extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
| 0.0 |
0.1 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.0 |
0.4 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 |
0.2 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.1 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.0 |
0.6 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
1.2 |
GO:0050691 |
regulation of defense response to virus by host(GO:0050691) |
| 0.0 |
0.2 |
GO:0051321 |
meiotic cell cycle(GO:0051321) |
| 0.0 |
1.4 |
GO:0045765 |
regulation of angiogenesis(GO:0045765) |
| 0.0 |
1.4 |
GO:0006364 |
rRNA processing(GO:0006364) |
| 0.0 |
0.1 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.3 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.0 |
0.9 |
GO:0042552 |
myelination(GO:0042552) |
| 0.0 |
0.5 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
